Gentex Corporation (GNTX) short interest & options flow
NASDAQGentex faced a significant downgrade from Goldman Sachs analyst Mark Delaney, who moved the rating from Neutral to Sell and cut the price target 13% to $20. The stock closed at $21.91 on October 5, implying downside from current levels. The downgrade marks a shift in tone as Gentex struggles against sector peers. The consensus remains Hold, with a mean target of $27.39, though sell-side conviction appears to be eroding across multiple analysts.
GNTX Goldman Sachs downgrades to Sell, slashes target to $20 from $23.
Gentex faced a significant downgrade from Goldman Sachs analyst Mark Delaney, who moved the rating from Neutral to Sell and cut the price target 13% to $20. The stock closed at $21.91 on October 5, implying downside from current levels. The downgrade marks a shift in tone as Gentex struggles against sector peers. The consensus remains Hold, with a mean target of $27.39, though sell-side conviction appears to be eroding across multiple analysts.
- Market cap
- $4.19B
- Next earnings
- 29 Jan 2027
Key data as of 8 Nov 2026
Latest signals on GNTX
- Analyst
GNTX Goldman Sachs downgrades to Sell, slashes target to $20 from $23.
- Short Interest
GNTX short interest surges 24.4% over one week to 8.5% of float, marking a 46% monthly climb amid rising bearish positioning.
- Options
GNTX put/call ratio hits 0.753, surging to 4.2 standard deviations above the 20-day mean of 0.235. Options traders are heavily favoring…
GNTX news and analysis
RSSNo long-form analysis yet for GNTX. Pulse alerts and the live data picture are available on ORTEX.
Open GNTX on ORTEX →Want the live picture for GNTX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GNTX — free to start on ORTEX.
Sign up for free →Open GNTX on ORTEX